Amine Benmoussa is Principal in BDC Capital’s Healthcare Venture Fund. He joined BDC Capital in 2011 and has over twelve years of venture and banking experience.
Prior to joining the BDC Capital’s Healthcare Venture Fund team, Amine was part of the Life Sciences investment team at FSTQ.
Amine currently serves on the board of directors of Clearwater Clinical. He previously served on the boards of Alethia Biotherapeutics, Circle Cardiovascular Imaging, Clementia Pharmaceuticals, Interface Biologics and Milestone Pharmaceuticals.
Amine holds a Bachelor of Computer Science from Concordia University and an MBA from HEC Montreal. He has also completed executive training in Private Equity and Venture Capital at the Harvard Business School, and in Corporate Governance at the Rotman School of Management.